Parametric design software for nanostructured CRISPR payloads
Parametric design software for nanostructured CRISPR payloads
批准号:
10602823
负责人:
Steven L Armentrout
金额:
$30.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-02-01 至 2024-04-30
关键词:
3-DimensionalAccelerationAffectAtomic Force MicroscopyAutomationBase PairingBiological SciencesBiomedical ResearchCRISPR/Cas technologyCapitalCell LineCellsClinicalClustered Regularly Interspaced Short Palindromic RepeatsComputer softwareDNADevelopmentEffectivenessEngineeringFaceFlow CytometryGeneticGenetic DiseasesGenetic EngineeringGenetic TemplateGenomeGenomicsGeometryGoalsHealthHourHumanHuman GenomeIn VitroKnock-inLegal patentLicensingMarketingMeasuresMedicalMedical ResearchMethodsMissionModificationNanostructuresNanotechnologyNational Institute of General Medical SciencesNucleic AcidsOligonucleotidesPerformancePersonsPhasePhase III Clinical TrialsPositioning AttributeProcessProtocols documentationResearchResearch PersonnelScienceServicesShapesSingle-Stranded DNASmall Business Innovation Research GrantSoftware DesignSoftware ToolsSpecific qualifier valueSpecificityStructureSystemTechniquesTestingTherapeutic StudiesTubular formationVariantVendorWritingarmbioinformatics toolbiomaterial compatibilityclinical applicationcombinatorialcommercial applicationcommercializationdesigndesign,build,testgene therapygenetic payloadgenome editingimprovedin silicoinhibitoriterative designmanufacturemolecular modelingnanocarriernanomaterialsnanomedicinenanosensorsnoveloperationpersonalized medicinerepairedscale upself assemblysoftware developmenttherapeutic DNAtherapeutic genome editing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
More than 300 million people worldwide are affected by a genetic health condition. Over 4,400 genetic
diseases have been identified; nearly all of which are considered rare, which limits the amount of research
each receives. Gene therapy is an attractive approach for treatment of genetic disease because of its broad
applicability. CRISPR-Cas9 genome editing systems (CRISPR) have revolutionized gene therapy research and
other fields of life science, however, no CRISPR-based treatments have reached the market and clinical
application still faces important challenges.
In this project, we aim to develop design automation software to help improve how genetic donor templates are
packaged for genomic integration via CRISPR, thereby increasing CRISPR editing efficiency. Whereas such
templates are usually delivered as unstructured (linear) single-stranded DNA, recent studies indicate genome
integration efficiency is significantly improved when templates are folded into compact shapes using
techniques from DNA nanotechnology. Such nanostructured genetic payloads (NGPs) for CRISPR have the
potential to become an essential component of genetic therapy and personalized medicine. The long-term goal
of the project is to provide researchers with software for designing more effective CRISPR treatments to
improve the lives of people with genetic health problems. Our solution will also advance other application
domains where DNA nanotechnology is being employed, such as nanomedicine, nanosensing and
biocompatible nanomaterials, thereby supporting the mission of the National Institute of General Medical
Sciences (NIGMS): improving the effectiveness of computational approaches in biomedical research.
Academic software exists to facilitate design of DNA nanostructures, however, these applications either require
extensive expertise or are limited to 3D wireframe designs. Design of a novel DNA nanostructure of modest
complexity that is not among a small set of simple designs can require hundreds of hours of expert labor.
Moreover, because NGPs are new to science, no software currently exists to automatically generate DNA
nanostructures for a given set of NGP design parameters. In Aim 1 of this project, we will employ an iterative
design-build-test development cycle we have used to bring other software products to market to develop novel
parametric design software (PDS) able to create NGPs automatically for a given genetic template and set of
design parameters. In Aim 2, we will simulate and synthesize eight NGPs and characterize them via molecular
modeling and atomic force microscopy to confirm they meet design specifications. We will then test these
NGPs for CRISPR editing efficiency against unstructured payload controls in vitro. In Phase II, we will enhance
the PDS and use it to explore the vast space of NGP designs for those that optimize CRISPR performance via
combinatorial testing across multiple cell lines, templates and insertion targets. Ultimately, we aim to
commercialize NGP software and design services to accelerate CRISPR research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A nanoengineering platform for programmable gene editing therapies against rare diseases
-
批准号:10699037
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2023
-
负责人:Steven L Armentrout
-
依托单位:
A multitargeted nanocarrier inhibitor of undruggable transcription factors for treating castration resistant prostate cancer
-
批准号:10415002
-
项目类别:
-
资助金额:$14.95万
-
财政年份:2021
-
负责人:Steven L Armentrout
-
依托单位:
A multitargeted nanocarrier inhibitor of undruggable transcription factors for treating castration resistant prostate cancer
-
批准号:10252316
-
项目类别:
-
资助金额:$25.05万
-
财政年份:2021
-
负责人:Steven L Armentrout
-
依托单位:
Smartphone phenotype collection for diagnostic screening of mild cognitive impairment
-
批准号:10255750
-
项目类别:
-
资助金额:$118.66万
-
财政年份:2018
-
负责人:Steven L Armentrout
-
依托单位:
Smartphone phenotype collection for diagnostic screening of mild cognitive impairment
-
批准号:10478979
-
项目类别:
-
资助金额:$74.26万
-
财政年份:2018
-
负责人:Steven L Armentrout
-
依托单位:
Mixed-Ligand Targeting of a Nano-Pharmaceutical Against GBM Stem Cells
-
批准号:8518927
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2011
-
负责人:Steven L Armentrout
-
依托单位:
Mixed-Ligand Targeting of a Nano-Pharmaceutical Against GBM Stem Cells
-
批准号:8201250
-
项目类别:
-
资助金额:$17.48万
-
财政年份:2011
-
负责人:Steven L Armentrout
-
依托单位:
海外基金